Your browser doesn't support javascript.
loading
Safety and efficacy data supporting U.S. FDA approval of intracameral phenylephrine and ketorolac 1.0%/0.3% for pediatric cataract surgery: clinical safety and pupil and pain management.
Wilson, M Edward; Trivedi, Rupal H; Plager, David A.
Affiliation
  • Wilson ME; From the Storm Eye Institute (Wilson, Trivedi), Medical University of South Carolina, Charleston, South Carolina, Indiana University (Plager), Indianapolis, Indiana, USA.
J Cataract Refract Surg ; 46(6): 873-878, 2020 Jun.
Article in En | MEDLINE | ID: mdl-32221151
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cataract / Ketorolac Type of study: Clinical_trials / Prognostic_studies Limits: Child / Child, preschool / Humans / Infant / Newborn Country/Region as subject: America do norte Language: En Journal: J Cataract Refract Surg Journal subject: OFTALMOLOGIA Year: 2020 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cataract / Ketorolac Type of study: Clinical_trials / Prognostic_studies Limits: Child / Child, preschool / Humans / Infant / Newborn Country/Region as subject: America do norte Language: En Journal: J Cataract Refract Surg Journal subject: OFTALMOLOGIA Year: 2020 Document type: Article Affiliation country: United States Country of publication: United States